The European Medicines Agency has again called for more resources to help it deal with the ongoing impact of COVID-19 as well as the general increase in its workload. It has specifically asked to retain 40 temporary staff posts that were created to help deal with pandemic-related activities during 2021-22 but that are scheduled to disappear in 2023.
Despite the “exceptional circumstances” it has faced over recent years, the EMA says it has managed to adapt to a...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?